Journal articles on the topic 'Virus diseases – Chemotherapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Virus diseases – Chemotherapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq." Journal of Communicable Diseases 55, no. 04 (March 13, 2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.
Full textRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 5 (October 1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.
Full textSnoeck, R., G. Andrei, and E. De Clercq. "Chemotherapy of varicella zoster virus infections." International Journal of Antimicrobial Agents 4, no. 3 (August 1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.
Full textPolsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus." Clinical Infectious Diseases 11, Supplement_7 (November 1, 1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.
Full textRice, W. G., and J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy." Reviews in Medical Virology 6, no. 4 (December 1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.
Full textFIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy." Journal of Antimicrobial Chemotherapy 24, no. 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.
Full textHan, Seung Beom, Hye Jo Shin, Eui Soo Lee, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, and Jin Han Kang. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (August 29, 2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.
Full textWainberg, Mark A., Andre Dascal, and Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases." Canadian Journal of Infectious Diseases 2, no. 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.
Full textBenke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, Suresh Gawande, Poonam Shelke, Somnath Dukare, Sweta Dhumal, Major Singh, and Vijay Mahajan. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment." Pathogens 12, no. 1 (January 12, 2023): 129. http://dx.doi.org/10.3390/pathogens12010129.
Full textDorobantu, Cristina M., Christian Harak, Rahel Klein, Lonneke van der Linden, Jeroen R. P. M. Strating, Hilde M. van der Schaar, Volker Lohmann, and Frank J. M. van Kuppeveld. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα." Antimicrobial Agents and Chemotherapy 60, no. 10 (August 1, 2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.
Full textPatel, R., and S. E. Barton. "Antiviral Chemotherapy in Genital Herpes Simplex Virus Infections." International Journal of STD & AIDS 6, no. 5 (September 1995): 320–28. http://dx.doi.org/10.1177/095646249500600503.
Full textRoy, Biswajit G. "Potential of small-molecule fungal metabolites in antiviral chemotherapy." Antiviral Chemistry and Chemotherapy 25, no. 2 (July 23, 2017): 20–52. http://dx.doi.org/10.1177/2040206617705500.
Full textDe Clercq, Erik. "Acyclic Nucleoside Phosphonates in the Chemotherapy of DNA Virus and Retrovirus Infections." Intervirology 40, no. 5-6 (1997): 295–303. http://dx.doi.org/10.1159/000150563.
Full textYeo, Winnie, Joyce L. Steinberg, John S. Tam, Paul K. S. Chan, Nancy W. Y. Leung, Kwok C. Lam, Tony S. K. Mok, and Philip J. Johnson. "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy." Journal of Medical Virology 59, no. 3 (November 1999): 263–69. http://dx.doi.org/10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x.
Full textRollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 2. Avian, Piscine, Canine, Porcine, Bovine and Equine Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 6 (December 1992): 311–26. http://dx.doi.org/10.1177/095632029200300601.
Full textHirsch, M. S. "Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects." Journal of Infectious Diseases 161, no. 5 (May 1, 1990): 845–57. http://dx.doi.org/10.1093/infdis/161.5.845.
Full textDylewski, J., and L. Thibert. "Failure of Tuberculosis Chemotherapy in a Human Immunodeficiency Virus-Infected Patient." Journal of Infectious Diseases 162, no. 3 (September 1, 1990): 778–79. http://dx.doi.org/10.1093/infdis/162.3.778.
Full textHenrich, Timothy J., Kristen S. Hobbs, Emily Hanhauser, Eileen Scully, Louise E. Hogan, Yvonne P. Robles, Kaitlyn S. Leadabrand, et al. "Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy." Journal of Infectious Diseases 216, no. 2 (June 3, 2017): 254–62. http://dx.doi.org/10.1093/infdis/jix265.
Full textThackray, Alana M., and Hugh J. Field. "Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy." Antimicrobial Agents and Chemotherapy 44, no. 1 (January 1, 2000): 97–102. http://dx.doi.org/10.1128/aac.44.1.97-102.2000.
Full textIdilman, R., M. Arat, E. Soydan, M. Toruner, I. Soykan, H. Akbulut, O. Arslan, et al. "Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies." Journal of Viral Hepatitis 11, no. 2 (March 2004): 141–47. http://dx.doi.org/10.1046/j.1365-2893.2003.00479.x.
Full textTien Phat, Do, Pham Bich Ngoc, and Chu Hoang Ha. "Methods to manage, protect and improve plant virus resistance." Vietnam Journal of Biotechnology 19, no. 4 (May 3, 2022): 607–18. http://dx.doi.org/10.15625/1811-4989/15584.
Full textOketani, Makoto, Akio Ido, Hirofumi Uto, and Hirohito Tsubouchi. "Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy." Hepatology Research 42, no. 7 (June 12, 2012): 627–36. http://dx.doi.org/10.1111/j.1872-034x.2012.00998.x.
Full textLocasciulli, A., M. Santamaria, G. Masera, E. Schiavon, A. Alberti, and G. Realdi. "Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy." Journal of Medical Virology 15, no. 1 (January 1985): 29–33. http://dx.doi.org/10.1002/jmv.1890150105.
Full textYeo, Winnie, Paul K. S. Chan, Henry L. Y. Chan, Frankie K. F. Mo, and Philip J. Johnson. "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis." Journal of Medical Virology 65, no. 3 (2001): 473–77. http://dx.doi.org/10.1002/jmv.2060.
Full textDe Clercq, Erik. "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections." International Journal of Antimicrobial Agents 7, no. 3 (August 1996): 193–202. http://dx.doi.org/10.1016/s0924-8579(96)00319-6.
Full textIshii, T., M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki. "Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis." Antimicrobial Agents and Chemotherapy 40, no. 1 (January 1996): 241–43. http://dx.doi.org/10.1128/aac.40.1.241.
Full textCingarlini, Sara. "Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature." Journal of Clinical Case Studies Reviews & Reports 5, no. 9 (September 30, 2023): 1–6. http://dx.doi.org/10.47363/jccsr/2023(5)258.
Full textZumla, A., and S. L. Croft. "Chemotherapy and immunity in opportunistic parasitic infections in AIDS." Parasitology 105, S1 (January 1992): S93—S101. http://dx.doi.org/10.1017/s0031182000075405.
Full textIlyushina, Natalia A., Erich Hoffmann, Rachelle Salomon, Robert G. Webster, and Elena A. Govorkova. "Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice." Antiviral Therapy 12, no. 3 (April 1, 2006): 363–70. http://dx.doi.org/10.1177/135965350701200302.
Full textSjöberg, Anita Herrström, Liya Wang, and Staffan Eriksson. "Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy." Antimicrobial Agents and Chemotherapy 45, no. 3 (March 1, 2001): 739–42. http://dx.doi.org/10.1128/aac.45.3.739-742.2001.
Full textYeo, Winnie, Paul K. S. Chan, Pun Hui, Wing M. Ho, Kwok C. Lam, Wing H. Kwan, Sheng Zhong, and Philip J. Johnson. "Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study." Journal of Medical Virology 70, no. 4 (June 2, 2003): 553–61. http://dx.doi.org/10.1002/jmv.10430.
Full textChen, Jungang, Samantha Kendrick, and Zhiqiang Qin. "Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas." Viruses 11, no. 12 (December 16, 2019): 1161. http://dx.doi.org/10.3390/v11121161.
Full textZon, Robin T., and Michael N. Neuss. "ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases." Journal of Oncology Practice 6, no. 4 (July 2010): 193–94. http://dx.doi.org/10.1200/jop.777007.
Full textUchiyama, Michihiro, Yotaro Tamai, and Takashi Ikeda. "Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma." International Journal of Infectious Diseases 14, no. 3 (March 2010): e265-e266. http://dx.doi.org/10.1016/j.ijid.2009.04.014.
Full textKorzh, Elena V. "Interstitial lung diseases in persons infected with human immunodeficiency virus." PULMONOLOGIYA 33, no. 6 (December 13, 2023): 841–48. http://dx.doi.org/10.18093/0869-0189-2023-33-6-841-848.
Full textGreiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (January 1, 2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.133.
Full textGreiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (January 1, 2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.20000133.
Full textKOTLYAR, V. K., S. V. FEDOROVICH, and O. L. SEGET. "IMPROVEMENT OF GRAPE CUTTINGS BY THERMOTHERAPY AGAINST GLRAV-3 VIRUS." Scientific Works of North Caucasian Federal Scientific Center of Horticulture Viticulture Wine-making 37 (September 2023): 107–10. http://dx.doi.org/10.30679/2587-9847-2023-37-107-110.
Full textNowak, J. S., and D. Januszkiewicz. "CHEMOTHERAPY OF CHILDREN WITH LYMPHOPROLIFERATIVE DISEASES AS A RISK FACTOR FOR HEPATITIS C VIRUS INFECTION. 127." Pediatric Research 41, no. 5 (May 1997): 770. http://dx.doi.org/10.1203/00006450-199705000-00146.
Full textRamphal, Raveena, Ronald M. Grant, Biljana Dzolganovski, Julie Constantin, Raymond Tellier, Upton Allen, Sheila Weitzman, Anne Matlow, Martin Petric, and Lillian Sung. "Herpes Simplex Virus in Febrile Neutropenic Children Undergoing Chemotherapy for Cancer." Pediatric Infectious Disease Journal 26, no. 8 (August 2007): 700–704. http://dx.doi.org/10.1097/inf.0b013e31805cdc11.
Full textNishida, Tsutomu, Naoki Hiramatsu, Masao Mizuki, Izumi Nagatomo, Hiroshi Kida, Keiko Tazumi, Shinichiro Shinzaki, et al. "Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic." Hepatology Research 43, no. 4 (August 6, 2012): 339–46. http://dx.doi.org/10.1111/j.1872-034x.2012.01073.x.
Full textShahgolzari, Mehdi, Srividhya Venkataraman, Anne Osano, Paul Achile Akpa, and Kathleen Hefferon. "Plant Virus Nanoparticles Combat Cancer." Vaccines 11, no. 8 (July 25, 2023): 1278. http://dx.doi.org/10.3390/vaccines11081278.
Full textPolyakov, Yu Yu, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, M. A. Mingalimov, S. A. Kardovskaya, M. Ya Smolyarchuk, et al. "Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2." Oncohematology 19, no. 2 (April 2, 2024): 101–8. http://dx.doi.org/10.17650/1818-8346-2024-19-2-101-108.
Full textIslas-Muñoz, B., B. Méndez-Sotelo, J. Reyes-Pérez, M. Jiménez-de los Santos, R. Herrera-Goepfert, and P. Volkow-Fernández. "Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C." International Journal of STD & AIDS 31, no. 11 (August 4, 2020): 1110–13. http://dx.doi.org/10.1177/0956462420943027.
Full textLi, Shu, Xiao-Yu Liu, Qiu Pan, Jian Wu, Zhi-Hao Liu, Yong Wang, Min Liu, and Xiao-Lian Zhang. "Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells." Viruses 11, no. 4 (April 24, 2019): 378. http://dx.doi.org/10.3390/v11040378.
Full textCastelli, Roberto, Riccardo Schiavon, Carlo Preti, and Laurenzia Ferraris. "HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy." Cardiovascular & Hematological Disorders-Drug Targets 20, no. 3 (November 26, 2020): 175–80. http://dx.doi.org/10.2174/1871529x20666200415121009.
Full textPham, Hoang. "Mathematical Modeling the Time-Delay Interactions between Tumor Viruses and the Immune System with the Effects of Chemotherapy and Autoimmune Diseases." Mathematics 10, no. 5 (February 27, 2022): 756. http://dx.doi.org/10.3390/math10050756.
Full textPuig-Basagoiti, Francesc, Tia S. Deas, Ping Ren, Mark Tilgner, David M. Ferguson, and Pei-Yong Shi. "High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery." Antimicrobial Agents and Chemotherapy 49, no. 12 (December 2005): 4980–88. http://dx.doi.org/10.1128/aac.49.12.4980-4988.2005.
Full textBeck, Sungjun, Zhe Zhu, Michelli F. Oliveira, Davey M. Smith, Jeremy N. Rich, Jean A. Bernatchez, and Jair L. Siqueira-Neto. "Mechanism of Action of Methotrexate Against Zika Virus." Viruses 11, no. 4 (April 10, 2019): 338. http://dx.doi.org/10.3390/v11040338.
Full textLoginova, S. Ya, V. N. Schukina, S. V. Savenko, R. V. Sakharov, and S. V. Borisevich. "Study of the Activity of Antiviral Drugs Against the Causative Agent of Chikungunya Fever in Cell Culture." Antibiotics and Chemotherapy 67, no. 11-12 (February 11, 2023): 10–15. http://dx.doi.org/10.37489/0235-2990-2022-67-11-12-10-15.
Full text